Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study.
Shimizu T, Miyake M, Nishimura N, Inoue K, Fujii K, Iemura Y, Ichikawa K, Omori C, Tomizawa M, Maesaka F, Oda Y, Miyamoto T, Sakamoto K, Kiba K, Tanaka M, Oyama N, Okajima E, Fujimoto K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K.
Shimizu T, et al. Among authors: tanaka m, tanaka n.
Cancers (Basel). 2022 Mar 29;14(7):1735. doi: 10.3390/cancers14071735.
Cancers (Basel). 2022.
PMID: 35406508
Free PMC article.